First Heartland Consultants’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
44,442
+2,292
+5% +$54.7K 0.07% 213
2026
Q1
$1.01M Buy
42,150
+1,268
+3% +$30.6K 0.08% 187
2025
Q4
$989K Buy
40,882
+13,891
+51% +$336K 0.08% 189
2025
Q3
$652K Buy
26,991
+1,274
+5% +$30.7K 0.05% 235
2025
Q2
$617K Buy
25,717
+7,838
+44% +$186K 0.05% 237
2025
Q1
$425K Buy
17,879
+997
+6% +$23.6K 0.04% 266
2024
Q4
$396K Buy
16,882
+2,298
+16% +$54.5K 0.04% 282
2024
Q3
$351K Buy
+14,584
New +$348K 0.04% 305
2023
Q1
Sell
-14,130
Closed -$326K 370
2022
Q4
$326K Sell
14,130
-961
-6% -$21.9K 0.05% 269
2022
Q3
$341 Buy
+15,091
New +$354K 0.03% 229

Other funds holding IBD

First Heartland Consultants's IBD Position: Q2 2026 in Review

First Heartland Consultants increased its Inspire Corporate Bond ETF (IBD) stake by 5.4% in Q2 2026, buying an estimated $54.7K and bringing the position to 44,442 shares worth $1.06M. The position accounts for 0.07% of the portfolio, ranked #213.

First Heartland Consultants first reported a position in IBD in Q3 2022 and has held it in 10 quarters since. 33 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • First Heartland Consultants held 44,442 shares of Inspire Corporate Bond ETF worth $1.06M as of Q2 2026.
  • First Heartland Consultants bought 2,292 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $54.7K.
  • Inspire Corporate Bond ETF made up 0.07% of First Heartland Consultants's portfolio in Q2 2026, its #213 holding.
  • First Heartland Consultants first reported a position in Inspire Corporate Bond ETF in Q3 2022 and has held it in 10 quarters since.
  • 33 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.